1-4 of 4
Asiong Jie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Influence of Renal Function on Outcome of VAD or Bortezomib, Doxorubicin, Dexamethasone (PAD) Induction Treatment Followed by High-Dose Melphalan (HDM): A Subgroup Analysis From the HOVON-65/GMMG-HD4 Randomized Phase III Trial for Newly Diagnosed Multiple Myeloma

Free
Christof Scheid, Pieter Sonneveld, Ingo Schmidt-Wolf, Bronno van der Holt, Thomas Hielscher, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Mathias Hänel, Edo Vellenga, Joerg Schubert, Igor Wolfgang Blau, Asiong Jie, Helgi Van de elde, Norma Peter, Martijn Schaafsma, Walter Lindemann, Marie Jose Kersten, Ulrich Duehrsen, Michel Delforge, Katja Weisel, Sandra Croockewit, Hans Martin, Shulamit Wittebol, Harry Schouten, Marinus van Marwijk-Kooy, Pierre Wijermans, Henk M Lokhorst, Hartmut Goldschmidt
Journal: Blood
Blood (2010) 116 (21): 2396.
https://doi.org/10.1182/blood.V116.21.2396.2396
Published: 2010
Journal Articles

HOVON-65/GMMG-HD4 Randomized Phase III Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (PAD) Vs VAD Followed by High-Dose Melphalan (HDM) and Maintenance with Bortezomib or Thalidomide In Patients with Newly Diagnosed Multiple Myeloma (MM)

Free
Pieter Sonneveld, Ingo Schmidt-Wolf, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Hans Salwender, Sonja Zweegman, Edo Vellenga, Joerg Schubert, Igor Wolfgang Blau, Asiong Jie, Berna Beverloo, Dirk Hose, Anna Jauch, Helgi van de Velde, Martijn Schaafsma, Walter Lindemann, Marie Jose Kersten, Ulrich Duehrsen, MD, Michel Delforge, Katja Weisel, Sandra Croockewit, Hans Martin, Shulamit Wittebol, Christof Scheid, Gerard Bos, Marinus van Marwijk-Kooy, Pierre Wijermans, Henk Lokhorst, Hartmut Goldschmidt
Journal: Blood
Blood (2010) 116 (21): 40.
https://doi.org/10.1182/blood.V116.21.40.40
Published: 2010
Journal Articles

Successful Harvesting of Peripheral Hematopoietic Stem Cells after Induction Treatment with Bortezomib, Adriamycin, Dexamethasone (PAD) in Patients with Newly Diagnosed Multiple Myeloma (MM)

Free
Hartmut Goldschmidt, Henk M. Lokhorst, Uta Bertsch, Bronno van der Holt, Laila el Jarari, Hans-Jürgen Salwender, Sonja Zweegman, Edo Vellenga, Jörg Schubert, Igor W. Blau, Asiong Jie, Berna Beverloo, Dirk Hose, Helgi van de Velde, Martyn Ronald Schaafsma, Marie Jose Kersten, Michel Delforge, Okke de Weerdt, Rene Van der Griend, Pierre Wijermans, Hans Martin, Christof Scheid, Mathias Hänel, Ingo G.H. Schmidt-Wolf, Pieter Sonneveld for the HOVON GMMG group
Journal: Blood
Blood (2008) 112 (11): 3470.
https://doi.org/10.1182/blood.V112.11.3470.3470
Published: 2008
Journal Articles

Final Analysis of HOVON-50 Randomized Phase III Study on the Effect of Thalidomide Combined with Adriamycine, Dexamethasone (AD) and High Dose Melphalan (HDM) in Patients with Multiple Myeloma (MM)

Free
Henk Lokhorst, Bronno van der Holt, Sonja Zweegman, MD, PhD, Peter A. Von Dem Borne, MD, PhD, Gerard M.J. Bos, MD, PhD, Sandra Croockewit, MD, PhD, Jan J. Cornelissen, MD, PhD, Marinus van Oers, Martyn Ronald Schaafsma, Harm Sinnige, MD, PhD, Michel Delforge, MD, PhD, Okke de Weerdt, Pierre W Wijermans, Shulamiet Wittebol, MD, PhD, Edo Vellenga, MD, PhD, Asiong Jie, Henriette Berenschot, MD, PhD, Marinus Marwijk-kooy, MD, PhD, Pieter Sonneveld, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 157.
https://doi.org/10.1182/blood.V112.11.157.157
Published: 2008